| Dr James A Dobbs, OD | |
|
207 S Main St., Enterprise, AL 36330-2544 | |
| (334) 347-8900 | |
| (334) 347-1480 |
| Full Name | Dr James A Dobbs |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 30 Years |
| Location | 207 S Main St., Enterprise, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720103781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | S-976-TA-522 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dobbs Eye Clinic P.a. | 0042233421 | 2 |
News Archive
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
Genervon Biopharmaceuticals LLC ("Genervon") today announced that it has analyzed and generated a Biomarker Data Report for its recent Phase 2a clinical trial for ALS disease modification.
A new article in the February issue of the Journal of the American College of Radiology provides a roadmap for imaging manufacturers to navigate the unique and increasingly complex U.S. regulatory and reimbursement environment. "Evidence Requirements for Innovative Imaging Devices: From Concept to Adoption," identifies and addresses the five phases of an imaging procedure's lifecycle and the distinct clinical evidence needs for each phase.
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 4 days ago
| Provider Name | Dobbs Eye Clinic P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1679690143 PECOS PAC ID: 0042233421 Enrollment ID: O20060111001036 |
News Archive
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
Genervon Biopharmaceuticals LLC ("Genervon") today announced that it has analyzed and generated a Biomarker Data Report for its recent Phase 2a clinical trial for ALS disease modification.
A new article in the February issue of the Journal of the American College of Radiology provides a roadmap for imaging manufacturers to navigate the unique and increasingly complex U.S. regulatory and reimbursement environment. "Evidence Requirements for Innovative Imaging Devices: From Concept to Adoption," identifies and addresses the five phases of an imaging procedure's lifecycle and the distinct clinical evidence needs for each phase.
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James A Dobbs, OD 207 S Main St, Enterprise, AL 36330-2544 Ph: (334) 347-8900 | Dr James A Dobbs, OD 207 S Main St., Enterprise, AL 36330-2544 Ph: (334) 347-8900 |
News Archive
The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
Genervon Biopharmaceuticals LLC ("Genervon") today announced that it has analyzed and generated a Biomarker Data Report for its recent Phase 2a clinical trial for ALS disease modification.
A new article in the February issue of the Journal of the American College of Radiology provides a roadmap for imaging manufacturers to navigate the unique and increasingly complex U.S. regulatory and reimbursement environment. "Evidence Requirements for Innovative Imaging Devices: From Concept to Adoption," identifies and addresses the five phases of an imaging procedure's lifecycle and the distinct clinical evidence needs for each phase.
Affecting almost 600,000 people worldwide every year, and with only a 50% survival rate, oral squamous cell carcinoma (OSCC) is one of the more common and deadly forms of cancer.
New cancer drugs allow doctors to tailor treatment based on the genetic profile of a patient's tumor. However, these drugs don't work at all in some patients, and they lose their effectiveness in others.
› Verified 4 days ago
Eye Care Associates, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 820 East Lee Street, Enterprise, AL 36330 Phone: 334-393-2020 Fax: 636-527-0766 | |
Dr. Douglas W Devore, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 820 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 | |
Lorie C Woods, OD Optometrist Medicare: Medicare Enrolled Practice Location: 812 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 Fax: 334-393-6936 | |
Bender Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1020 B Boll Weevil Circle, Enterprise, AL 36330 Phone: 334-347-2732 Fax: 334-347-2732 | |
Dr. Brian Edward Kurtz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 820 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 | |
Dr. Gary Dale Dobbs, Optometrist Medicare: Medicare Enrolled Practice Location: 207 S Main St, Enterprise, AL 36330 Phone: 334-347-8900 Fax: 334-347-1480 | |
Dr. Velvet Jeter Maddox, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 607-c Boll Weevil Circle, Enterprise, AL 36330 Phone: 334-347-6599 Fax: 334-347-6599 |